Did you know that the number of rare disease patients in China is estimated to be more than 20 million, with more than 200,000 new cases registered every year?
Download this infographic to find out more, and how our dedicated emerging markets experts can offer guidance for pharma companies to consider.
Jump to a slide with the slide dots.
Manufacturers of orphan drugs are being awarded longer market exclusivity, reduced regulatory fees and tax incentives.
Read moreMarket opportunity as well as our experience and expertise in the growing area of rare diseases and orphan drugs.
Read moreFind out about our team of emerging market experts with this infographic outlining our experience and expertise across a vast number of regions.
Read moreRapport is our monthly newsletter where we share our latest expertise and experience.